Literature DB >> 12854025

Cystoid macular edema in uveitis.

Narciss Okhravi1, Susan Lightman.   

Abstract

Cystoid macular edema (CME) can cause profound visual loss and is one of the major causes of legal blindness in patients with uveitis. It can complicate virtually any type of acute or chronic, anterior or posterior uveitis. When mild and of short duration, CME may respond to treatment used to control the intraocular inflammation. However, patients may need more aggressive treatment with local and systemic steroid therapy and other immunosuppressive drugs. Unfortunately, CME may become refractory to all currently available therapies and result in severe visual loss.

Entities:  

Mesh:

Year:  2003        PMID: 12854025     DOI: 10.1076/ocii.11.1.29.15582

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  11 in total

1.  Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.

Authors:  Leyla Suna Atmaca; F Nilüfer Yalçindağ; Ozden Ozdemir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

2.  Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography.

Authors:  Valeria Albano; Silvana Guerriero; Claudio Furino; Giancarlo Sborgia; Alessandra Sborgia; Rosanna Dammacco; Francesco Boscia; Giovanni Alessio
Journal:  Int Ophthalmol       Date:  2022-05-22       Impact factor: 2.029

3.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.

Authors:  Zhenyu Dong; Kenichi Namba; Nobuyoshi Kitaichi; Chiho Goda; Mizuki Kitamura; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

4.  Uveitic Macular Edema: Treatment Update.

Authors:  Raquel Goldhardt; Bradley Simon Rosen
Journal:  Curr Ophthalmol Rep       Date:  2016-02-18

5.  Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.

Authors:  Rushmia Karim; Evripidis Sykakis; Susan Lightman; Samantha Fraser-Bell
Journal:  Clin Ophthalmol       Date:  2013-06-11

6.  Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.

Authors:  Jennifer E Thorne; Elizabeth A Sugar; Janet T Holbrook; Alyce E Burke; Michael M Altaweel; Albert T Vitale; Nisha R Acharya; John H Kempen; Douglas A Jabs
Journal:  Ophthalmology       Date:  2018-09-27       Impact factor: 14.277

7.  The effects of intravitreal bevacizumab in infectious and noninfectious uveitic macular edema.

Authors:  Hassan Al-Dhibi; Issam H Hamade; Ali Al-Halafi; Maan Barry; Charbel Bou Chacra; Vishali Gupta; Khalid F Tabbara
Journal:  J Ophthalmol       Date:  2014-07-21       Impact factor: 1.909

8.  Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study.

Authors:  Barbara Berasategui; Alex Fonollosa; Joseba Artaraz; Ioana Ruiz-Arruza; Jose Ríos; Jessica Matas; Victor Llorenç; David Diaz-Valle; Marina Sastre-Ibañez; Pedro Arriola-Villalobos; Alfredo Adan
Journal:  BMC Ophthalmol       Date:  2018-07-20       Impact factor: 2.209

9.  Bilateral macular thickening in mild unilateral anterior uveitis: is HLA-B27 involved?

Authors:  Alexandra Wexler; Trond Sand; Tor B Elsås
Journal:  BMC Ophthalmol       Date:  2012-07-29       Impact factor: 2.209

10.  Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis

Authors:  Murat Hasanreisoğlu; Hüseyin Baran Özdemir; Kaan Özkan; Murat Yüksel; Zeynep Aktaş; Hatice Tuba Atalay; Şengül Özdek; Gökhan Gürelik
Journal:  Turk J Ophthalmol       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.